NCT02103296
Completed
Not Applicable
Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight (VLBW) Preterm Neonates: A Multi-center Randomized Clinical Trial
Capt Alicia Prescott6 sites in 1 country80 target enrollmentFebruary 2014
ConditionsAnemia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anemia
- Sponsor
- Capt Alicia Prescott
- Enrollment
- 80
- Locations
- 6
- Primary Endpoint
- Absolute hemoglobin concentration
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The goal of this protocol is to establish a randomized clinical trial comparing the use of cord blood vs. infant blood with the primary outcome of comparing both the absolute hemoglobin concentration and the percent change in hemoglobin concentration from baseline around 24 hours of life.
Investigators
Capt Alicia Prescott
Associate Investogator
San Antonio Military Medical Center
Eligibility Criteria
Inclusion Criteria
- •Birth weight less than 1200g or Gestational Age less than 30 weeks born at participating medical centers
Exclusion Criteria
- •No specific exclusion criteria
Outcomes
Primary Outcomes
Absolute hemoglobin concentration
Time Frame: 24 hours of life
Percent change in hemoglobin concentration from baseline
Time Frame: 24 hours of life
Secondary Outcomes
- Hemoglobin concentration at one week of life(one week)
- Hemoglobin concentration at time of hospital discharge(Approximately 10 - 16 weeks)
- Number of blood donor exposures(Participants will be followed from birth until time of hospital discharge, an expected average of 13 weeks.)
- Use of Vasopressors(Participants will be followed from birth until time of hospital discharge, an expected average of 13 weeks.)
- Number/volume of packed red blood cell (pRBC) transfusions(Participants will be followed from birth until time of hospital discharge, an expected average of 13 weeks)
- Head Ultrasound(Read at 7 Days of life and at hospital discharge which is approximately 13 weeks of age)
Study Sites (6)
Loading locations...
Similar Trials
Completed
Phase 2
Cellular Therapy With Cord Blood CellsMultiple MyelomaLeukemiaLymphomaNCT00427557M.D. Anderson Cancer Center31
Completed
Phase 1
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood CellsMDSAnemia, AplasticInborn Errors of MetabolismCongenital Marrow FailureCongenital Immunodeficiency SyndromeNCT00692926Joanne Kurtzberg, MD37
Terminated
Not Applicable
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaMultiple MyelomaLymphoma, Large-Cell, DiffuseLymphoma, Mantle-CellLymphoma, T-Cell, PeripheralT-NK Cell LymphomaHodgkin DiseaseNCT00514722University of California, San Francisco4
Completed
Not Applicable
Umbilical Cord Milking for Neonates With Hypoxic Ischemic EncephalopathyHypoxic Ischemic EncephalopathyUmbilical Cord MilkingNCT02287077Thomas Jefferson University101
Unknown
Not Applicable
Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture HealingBone NonunionNCT04997590Qianfoshan Hospital40